DECREASED TEICOPLANIN SUSCEPTIBILITY OF METHICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCUS-AUREUS

被引:95
作者
MAINARDI, JL
SHLAES, DM
GOERING, RV
SHLAES, JH
ACAR, JF
GOLDSTEIN, FW
机构
[1] FDN HOP ST JOSEPH, MICROBIOL MED LAB, F-75674 PARIS 14, FRANCE
[2] VET AFFAIRS MED CTR, RES SERV, CLEVELAND, OH USA
[3] CASE WESTERN RESERVE UNIV, SCH MED, DIV INFECT DIS, CLEVELAND, OH USA
[4] CREIGHTON UNIV, SCH MED, DEPT MED MICROBIOL, OMAHA, NE USA
关键词
D O I
10.1093/infdis/171.6.1646
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Between February 1992 and February 1993, 12 patients were seen who were infected or colonized with methicillin-resistant strains of Staphylococcus aureus. The strains had decreased susceptibility to teicoplanin (MICs, 8-16 mu g/mL). Field inversion gel electrophoresis showed the strains belonged to three related clones (A(1), A(2), and A(3)). The patients were thought to ha,;e acquired the strains nosocomially, Consistent with results of laboratory studies of teicoplanin-resistant S. aureus, all but 1 strain expressed a 35-kDa membrane protein, and 9 strains expressed increased levels of penicillin-binding protein 2 complex. Six strains were isolated from patients treated with glycopeptides. These data suggest that nosocomial transmission of S. aureus with decreased teicoplanin susceptibility may occur during glycopeptide use and that such strains develop resistance by a mechanism associated with the appearance of a 35-kDa membrane protein. Surveillance is necessary to monitor for the potential selection of resistant clones that may be capable of dissemination.
引用
收藏
页码:1646 / 1650
页数:5
相关论文
共 15 条
[1]  
ACAR J, 1993, PATHOL BIOL, V41, P741
[2]   FAILURE OF TEICOPLANIN THERAPY IN 2 NEUTROPENIC PATIENTS WITH STAPHYLOCOCCAL SEPTICEMIA WHO RECOVERED AFTER ADMINISTRATION OF VANCOMYCIN [J].
BRUNET, F ;
VEDEL, G ;
DREYFUS, F ;
VAXELAIRE, JF ;
GIRAUD, T ;
SCHREMMER, B ;
MONSALLIER, JF .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (02) :145-147
[4]   EFFECTS OF DOSAGE, PEAK AND TROUGH CONCENTRATIONS IN SERUM, PROTEIN-BINDING, AND BACTERICIDAL RATE ON EFFICACY OF TEICOPLANIN IN A RABBIT MODEL OF ENDOCARDITIS [J].
CHAMBERS, HF ;
KENNEDY, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (04) :510-514
[5]   CHARACTERIZATION OF STAPHYLOCOCCUS-AUREUS ISOLATES WITH DECREASED SUSCEPTIBILITY TO VANCOMYCIN AND TEICOPLANIN - ISOLATION AND PURIFICATION OF A CONSTITUTIVELY PRODUCED PROTEIN ASSOCIATED WITH DECREASED SUSCEPTIBILITY [J].
DAUM, RS ;
GUPTA, S ;
SABBAGH, R ;
MILEWSKI, WM .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (05) :1066-1072
[6]  
FEY PD, 1992, 32ND INT C ANT AG CH, P359
[7]   FAILURE OF TREATMENT WITH TEICOPLANIN AT 6 MILLIGRAMS KILOGRAM DAY IN PATIENTS WITH STAPHYLOCOCCUS-AUREUS INTRAVASCULAR INFECTION [J].
GILBERT, DN ;
WOOD, CA ;
KIMBROUGH, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (01) :79-87
[8]  
GOERING RV, 1993, INFECT CONT HOSP EP, V14, P595
[9]   RAPID METHOD FOR EPIDEMIOLOGIC EVALUATION OF GRAM-POSITIVE COCCI BY FIELD INVERSION GEL-ELECTROPHORESIS [J].
GOERING, RV ;
WINTERS, MA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (03) :577-580
[10]   EMERGENCE OF TEICOPLANIN RESISTANCE DURING THERAPY OF STAPHYLOCOCCUS-AUREUS ENDOCARDITIS [J].
KAATZ, GW ;
SEO, SM ;
DORMAN, NJ ;
LERNER, SA .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (01) :103-108